Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Squamous Non-Small Cell Lung Cancer sqNSCLC”

18 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 18 results

Testing effectiveness (Phase 2)Looking for participantsNCT05910827
What this trial is testing

A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers

Who this might be right for
Advanced or Metastatic Squamous Non-Small Cell Lung CancerAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Esophageal Squamous Cell Carcinoma+4 more
Hummingbird Bioscience 398
Testing effectiveness (Phase 2)UnknownNCT04976647
What this trial is testing

HLX07 + HLX10 With or Without Chemotherapy Versus HLX10 With Chemotherapy in First Line sqNSCLC

Who this might be right for
Squamous Non-small-cell Lung Cancer
Shanghai Henlius Biotech 156
Early research (Phase 1)Not Yet RecruitingNCT07073183
What this trial is testing

Safety and Tolerability of CVHNLC Plus Pembrolizumab in Patients With Squamous Non Small-Cell Lung Cancer (sqNSCLC)

Who this might be right for
Squamous NSCLC
CureVac 36
Testing effectiveness (Phase 2)Looking for participantsNCT05613413
What this trial is testing

A Pilot Phase II Study of Maintenance Cabozantinib Plus Pembrolizumab for Patients With Metastatic Squamous Non-Small Cell Lung Cancer (sqNSCLC)

Who this might be right for
Metastatic Squamous Non-Small Cell Lung Carcinoma
University of Illinois at Chicago 36
Large-scale testing (Phase 3)Not Yet RecruitingNCT06319313
What this trial is testing

Efficacy and Safety of JMT101 Combined Wth Docetaxel / HB1801 in Patients With Squamous Cell Non-Small Cell Lung Cancer

Who this might be right for
Squamous Cell Non-small Cell Lung Cancer
Shanghai JMT-Bio Inc. 534
Testing effectiveness (Phase 2)Ended earlyNCT05275673
What this trial is testing

Sapanisertib in Relapsed/Refractory NFE2L2-Mutated and Wild-Type Squamous Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerSquamous Non-small-cell Lung CancerSquamous Non-Small Cell Neoplasm of Lung+1 more
Faeth Therapeutics 7
Large-scale testing (Phase 3)Looking for participantsNCT07416474
What this trial is testing

RC148 Plus Platinum-Based Chemotherapy vs Tislelizumab Plus Platinum-Based Chemotherapy for First-Line Squamous Non-Small Cell Lung Cancer (sqNSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
RemeGen Co., Ltd. 574
Large-scale testing (Phase 3)Looking for participantsNCT07217301
What this trial is testing

IBI363 vs Docetaxel in Patients With Advanced Squamous Lung Cancer After Standard Treatments Have Failed

Who this might be right for
iO Resistant sqNSCLC
Fortvita Biologics (USA)Inc. 600
Large-scale testing (Phase 3)Not Yet RecruitingNCT07318883
What this trial is testing

A Phase II/III Clinical Study to Evaluate HLX07 in Combination With Serplulimab and Chemotherapy Versus Placebo in Combination With Serplulimab or Pembrolizumab and Chemotherapy as First-Line Treatment in Advanced Squamous Non-Small Cell Lung Cancer

Who this might be right for
Squamous NSCLC
Shanghai Henlius Biotech 720
Testing effectiveness (Phase 2)Looking for participantsNCT05902988
What this trial is testing

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

Who this might be right for
Advanced Solid TumorHigh Grade Serous Adenocarcinoma of OvarySquamous Non-small-cell Lung Cancer+7 more
Volastra Therapeutics, Inc. 200
Early research (Phase 1)Looking for participantsNCT07241039
What this trial is testing

Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors

Who this might be right for
Advanced Squamous Tumors
AbbVie 220
Early research (Phase 1)Study completedNCT01884285
What this trial is testing

AZD8186 First Time In Patient Ascending Dose Study

Who this might be right for
Advanced Castrate-resistant Prostate Cancer CRPCSquamous Non-Small Cell Lung Cancer sqNSCLCTriple Negative Breast Cancer TNBC
AstraZeneca 147
Not applicableNo Longer AvailableNCT02475382
What this trial is testing

Expanded Access Program With Nivolumab Therapy for Treatment of Advanced/Metastatic SqNSCLC or Non-SqNSCLC After One Prior Systemic Regimen

Who this might be right for
Squamous Non-Small Cell Lung CancerNon-squamous Non-Small Cell Lung Cancer
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06747169
What this trial is testing

Efficacy and Safety of Sintilimab Combined with Nab-PP Plus Rh-endostatin in Locally Advanced/advanced and Recurrent Metastatic Squamous Non-small Cell Lung Cancer: a Single-arm, Multicenter Clinical Study

Who this might be right for
Squamous Non-Small Cell Lung Cancer SqNSCLC
Jian-Guo Zhou, MD, PhD 32
Testing effectiveness (Phase 2)Ended earlyNCT03827850
What this trial is testing

FGFR Inhibitor in FGFR Dysregulated Cancer

Who this might be right for
Lung CancerNSCLCPulmonary Neoplasm+2 more
Lung Cancer Group Cologne 22
Early research (Phase 1)Ended earlyNCT05267470
What this trial is testing

Bemarituzumab Monotherapy and Combination With Other Anti-cancer Therapy in SqNSCLC With FGFR2b Overexpression (FORTITUDE-201)

Who this might be right for
Squamous-Cell Non-Small-Cell Lung Cancer
Amgen 74
Testing effectiveness (Phase 2)Study completedNCT02409368
What this trial is testing

An Open-Label, Multicenter Clinical Trial With Nivolumab (BMS-936558) Monotherapy in Subjects With Advanced or Metastatic Squamous Cell (Sq) Non-Small Cell Lung Cancer (NSCLC) Who Have Received at Least One Prior Systemic Regimen for the Treatment of Stage IIIb/IV SqNSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Bristol-Myers Squibb 812
Testing effectiveness (Phase 2)Active Not RecruitingNCT03485209
What this trial is testing

Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors

Who this might be right for
Colorectal NeoplasmsCarcinoma, Non-Small-Cell LungExocrine Pancreatic Cancer+1 more
Seagen, a wholly owned subsidiary of Pfizer 350